Aflac Incorporated (NYSE: AFL) announced today that Japan Post will be expanding the number of post offices selling Aflac cancer products to an additional 10,064 starting July 1, 2015, which will bring the total number of post offices selling Aflac cancer products to 20,076 throughout Japan.
As stated last week at the company's financial analysts briefing, Aflac Japan expects third sector sales, which include cancer and medical products, to grow by an average of 15% for the first nine months of 2015, and potentially be down significantly in the fourth quarter due to difficult comparisons from the prior year's final quarter. As also communicated, the company will share its expectation for Aflac Japan's full year sales with the second quarter earnings release scheduled for July 28, 2015.
Aflac Chairman and CEO Dan Amos commented: "I am extremely pleased that starting in July, more than 20,000 post offices in Japan will be carrying our cancer insurance products. This expansion further demonstrates the strength of our strategic alliance with Japan Post Group and our commitment to working together to be there for the people throughout all regions of Japan in their time of need."
RNA micelles enable targeted chemotherapy without immune toxicity